Caitong International Asset Management’s Boundless Bio BOLD Stock Holding History

Caitong International Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3	Buy	+3	New	+$4	﹤0.01%	2400

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Caitong International Asset Management's BOLD Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Boundless Bio (BOLD) in Q1 2026: 3 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #2400 among its holdings.

36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

Caitong International Asset Management held 3 shares of Boundless Bio worth $3 as of Q1 2026.
Boundless Bio was a new Caitong International Asset Management position in Q1 2026.
Boundless Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2400 holding.
36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.